Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi
Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi
Not yet recruiting · NCT07804368 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, blastomycosis, coccidioidomycosis, dermatomycosis, fungal infectious disease, fungal lung infectious disease, histoplasmosis, lung disorder, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin disorder caused by infection | Not yet recruiting | Phase 2 | 2026-09-04 | NCT07804368 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centers for Disease Control and Prevention | 84 |
| University of Alabama at Birmingham | 467 |
| University of Minnesota | 344 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arizona State University - Tempe Campus | Tempe | United States | 1 |
| Mayo Clinic | Phoenix | United States | 50 |
| UCSF Fresno | Fresno | United States | 1 |
| University of California, Davis | Davis | United States | 12 |